Can-Fite BioPharma Ltd. (TLV:CANF)
Israel · Delayed Price · Currency is ILS · Price in ILA 1.000
0.00 (0.00%)
Jan 1, 2026, 10:15 AM IDT
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of 51.22 million as of December 31, 2025. Its market cap has decreased by -13.60% in one year.
Market Cap
51.22M
Enterprise Value
29.77M
Revenue
1.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.00
Market Cap Chart
Since June 12, 2006, Can-Fite BioPharma's market cap has increased from 16.04M to 51.22M, an increase of 219.35%. That is a compound annual growth rate of 6.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 1, 2026 | 51.22M | - |
| Dec 31, 2025 | 51.22M | -9.64% |
| Dec 31, 2024 | 56.68M | 77.98% |
| Dec 31, 2023 | 31.85M | -53.53% |
| Dec 29, 2022 | 68.52M | -42.86% |
| Dec 30, 2021 | 119.91M | 29.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 115.35B |
| Danel (Adir Yeoshua) | 2.89B |
| Kamada | 1.31B |
| BrainsWay | 1.19B |
| SofWave Medical | 1.01B |
| Bait Bakfar | 991.66M |
| Ilex Medical | 749.38M |
| Novolog (Pharm-Up 1966) | 655.96M |